Starting on January 1, 2027, the list price for these medications will drop to $675-per-month for each drug
Sobo or their prescribing clinician when side effects are persistent, worsening, confusing, or interfering with nutrition, hydration, bowel function, energy, sleep, or daily life
doi:10.3390/diseases13050127 10
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomized, 52-week, phase III, double-blind, parallel-treatment trial
This is an oral medication in the sense that were used to an oral medication that we can just put it in our Monday, Tuesday, Wednesday, Thursday tray and take it with our other oral medications without regard to food or most worries about drug interactions or anything like that, Eli Lilly CEO Dave Ricks told me in an interview last week